Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

Details for Australian Patent Application No. 2008218962 (hide)

Owner Theravance, Inc.

Inventors Husfeld, Craig; Lange, Christopher; Mu, Yongqi; Ji, Yu-Hua; Lee, Rick

Agent Davies Collison Cave

Pub. Number AU-A-2008218962

PCT Pub. Number WO2008/103426

Priority 60/903,110 23.02.07 US

Filing date 21 February 2008

Wipo publication date 28 August 2008

International Classifications

C07D 207/08 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 207/09 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/103426 Priority application(s): WO2008/103426

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008218968-Engineered anti-IL-23p19 antibodies

2008218958-Coated seeds and methods of making coated seeds